Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
225.2 SEK | -2.93% | -8.54% | +19.55% |
04-25 | Transcript : Bonesupport Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
04-25 | Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 118
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cerament Gentamicin and Ceramanent Vancomycin
60.6
%
| 112 | 34.1 % | 358 | 60.6 % | +219.37% |
Cerament Bone Void Filler
37.7
%
| 210 | 63.9 % | 223 | 37.7 % | +6.11% |
Other
1.6
%
| 6 | 1.9 % | 10 | 1.6 % | +52.14% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
74.9
%
| 217 | 66.0 % | 442 | 74.9 % | +104.01% |
United Kingdom
12.4
%
| 49 | 14.8 % | 73 | 12.4 % | +51.03% |
Europe and Rest of the World
10.8
%
| 54 | 16.3 % | 64 | 10.8 % | +18.62% |
Sweden
2.0
%
| 10 | 2.9 % | 12 | 2.0 % | +19.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Emil Billbäck
CEO | Chief Executive Officer | 54 | 18-02-28 |
Hakan Johansson
DFI | Director of Finance/CFO | 61 | 18-10-31 |
Chief Operating Officer | - | 21-11-30 | |
Chief Tech/Sci/R&D Officer | 50 | 17-03-31 | |
Annelie Vikner
IRO | Public Communications Contact | 53 | 19-02-28 |
Michael Roth
PRN | Corporate Officer/Principal | - | 20-05-31 |
Kristina Ingvar
LAW | General Counsel | 52 | 20-01-31 |
Helena Brandt
HRO | Human Resources Officer | 59 | 17-10-15 |
Linda Butcher
PRN | Corporate Officer/Principal | 61 | 09-12-31 |
Fergus MacLeod
PRN | Corporate Officer/Principal | 54 | 19-11-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Chairman | 69 | 17-02-28 | |
Director/Board Member | 68 | 16-08-31 | |
Mary O'Connor
BRD | Director/Board Member | - | - |
Christine Rankin
BRD | Director/Board Member | 60 | 22-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,142,060 | 0 | 0 | 89.77 % |
Stock B | 1 | 65,055,575 | 59,425,845 ( 91.35 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BONESUPPORT HOLDING AB 100.00% | 1,642,438 | 100.00% | 35,021,968 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.55% | 1.39B | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
+56.84% | 25.23B | |
-14.96% | 15.36B | |
-9.14% | 11.95B | |
-16.35% | 11.6B | |
-43.00% | 11.51B | |
+6.37% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- BONEX Stock
- Company Bonesupport Holding AB